JAMA Dermatology

Papers
(The H4-Index of JAMA Dermatology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
JAMA Dermatology802
Perceptions of US-Based Muslim Patients of Their Dermatology Care378
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil328
Error in Author Name235
Error in Author Surname in Byline182
Widespread Erythematous Plaques With Prominent Telangiectases152
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus151
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals140
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity127
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination123
JAMA Dermatology110
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database106
Melanoma Screening104
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?100
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults86
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin84
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis81
Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis78
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis76
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab75
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records72
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia71
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers69
Current State of Dermatology Mobile Applications With Artificial Intelligence Features63
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention62
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis61
Group Omitted From Article Byline60
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement59
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage57
Treatment of Kimura Disease With Dupilumab56
Smoking Cessation and Risk of Hidradenitis Suppurativa Development55
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa52
Patient-Reported Outcomes in Dermatology50
Ultraprocessed Food Intake and Psoriasis49
Alopecia Areata49
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars49
Skin Cancer Care in US Veterans—Serving Those Who Served48
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults48
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa48
Parental E-Cigarette Use and Pediatric Atopic Dermatitis47
Cutaneous Angiosarcoma46
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark43
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice42
Assessment of Cutaneous Vasculitis and Quality of Life42
0.15241289138794